MAPT and epilepsy: A subgroup analysis of individuals younger versus older than 65 years of age showed similar significant changes in the Aβ42 levels, whereas T-tau and P-tau concentrations were significantly higher in the epilepsy compared with the non-epilepsy group only among younger individuals.